Identification of endogenous retroviruses linked to IL-1-mediated immunopathology in severe COVID-19

When a virus invades the human body, the immune system usually responds with a precise, coordinated attack. However, in severe cases of COVID-19, this defense mechanism can go into overdrive, causing the body to damage its own tissues in a chaotic burst of inflammation. This dangerous state, known as immunopathology, is driven by a flood of signaling proteins that tell immune cells to attack, often leading to respiratory failure and organ damage. Hidden within the human genetic code are ancient remnants of viruses that infected our ancestors millions of years ago. These "endogenous retroviruses" are normally locked down and silent, but under certain stress conditions, they can wake up. Scientists have long wondered if these sleeping genetic ghosts play a role in modern diseases, particularly in the way the immune system sometimes turns against itself during severe infections.

A team of researchers at the University of British Columbia set out to investigate whether these ancient viral remnants are active during severe COVID-19 and if they contribute to the dangerous inflammation seen in the sickest patients. By analyzing genetic data from the blood of patients with severe disease, the scientists discovered a specific set of these dormant viruses that had become active. They found that when these viral sequences woke up, they were tightly linked to the same inflammatory pathways that cause the most damage in severe COVID-19. The study suggests that the activation of these ancient genetic elements is not just a side effect of the infection, but a potential driver of the immune system's harmful overreaction.

The researchers began by examining large datasets of genetic material taken from the blood of patients with severe COVID-19 and comparing them to healthy individuals. They were looking for specific locations in the genome where these ancient viral sequences were being transcribed into RNA, a sign that they were active. After filtering out signals that might have come from other nearby genes, they identified thirty-three distinct viral locations that were significantly more active in severe cases than in healthy people. The researchers called this collection the "severe COVID-19 signature." These active viral sequences were found across many different chromosomes and included various types of ancient viral families, showing that the phenomenon was not limited to just one type of genetic element.

To understand why these viruses woke up, the team looked at the cellular machinery responsible for keeping them silent. In a healthy state, the body uses specific proteins to coat these viral sequences and keep them turned off. The study found that in severe COVID-19 patients, the levels of these silencing proteins were lower, while other enzymes that remove the "off" switches were higher. This shift in the chemical environment of the cell appears to have unlocked the viral sequences, allowing them to be read and expressed. The researchers also noted that the activity of these viral sequences correlated strongly with the expression of genes involved in inflammation, suggesting a direct link between the waking viruses and the body's inflammatory response.

The connection to disease severity became even clearer when the researchers looked at specific clinical outcomes. They found that a subset of six of these active viral sequences was particularly associated with patients who required admission to the intensive care unit. The higher the combined activity of these six sequences, the fewer days a patient remained in the hospital without needing care, indicating a worse clinical outcome. Furthermore, when they compared patients with severe COVID-19 to those who had similar symptoms but tested negative for the virus, they found that these specific viral sequences were uniquely active in the COVID-19 patients. This suggests that the activation is a specific feature of the severe form of the disease, rather than a general reaction to any illness.

Perhaps the most compelling evidence came from looking at how the body responds to treatment. The researchers analyzed data from patients who received a drug called anakinra, which blocks a specific inflammatory signal known as interleukin-1. In patients who responded well to this treatment, the activity of the signature viral sequences dropped significantly. This finding implies that the inflammatory signals driving the disease are also responsible for keeping these ancient viruses active. When the inflammation was reduced, the viruses were effectively silenced again, reinforcing the idea that these viral sequences are part of the inflammatory cycle that harms the patient.

To pinpoint exactly where this was happening inside the body, the team examined single-cell data, which allows scientists to see gene activity in individual cells rather than a mixture of many. They discovered that the active viral sequences were most prominent in two types of cells: macrophages, which are immune cells that patrol the body for threats, and erythroid precursor cells, which are developing red blood cells. In these specific cells, the presence of the active viral sequences was accompanied by a higher expression of genes related to the immune system's alarm signals. This means that within the very cells that were most active in the disease, the waking viruses were co-existing with a heightened state of immune alertness.

The study does not claim that these ancient viruses are the sole cause of severe COVID-19, nor does it suggest that they are infectious in the way a modern virus is. Instead, the findings point to a complex relationship where the body's attempt to fight the virus inadvertently triggers the activation of these dormant genetic elements. These elements, in turn, appear to amplify the inflammatory response, creating a feedback loop that worsens the disease. The researchers propose that these specific viral sequences could serve as markers to identify patients at risk of severe outcomes and that targeting the inflammatory pathways that wake them up might offer new ways to treat the disease. By uncovering the role of these ancient genetic remnants, the study provides a new perspective on why some individuals suffer such severe reactions to the virus, highlighting a hidden layer of our own biology that becomes active when we are most vulnerable.